Monoclonal antibodies are Y-shaped proteins built from two identical heavy and light chains. Their variable regions form a paratope that binds a single antigen with high affinity and specificity, while the constant Fc region drives immune effector functions such as ADCC, CDC, and complement activation — making mAbs a precise, versatile, and clinically validated therapeutic modality.
We design and engineer highly specific monoclonal antibodies optimized for targeted therapy, developability, and clinical translation.
